| Primary |
| Psoriasis |
20.9% |
| Product Used For Unknown Indication |
18.6% |
| Dermatosis |
9.3% |
| Eczema |
7.0% |
| Skin Disorder |
7.0% |
| Alopecia |
4.7% |
| Arthritis |
4.7% |
| Drug Use For Unknown Indication |
4.7% |
| Acne |
2.3% |
| Alopecia Areata |
2.3% |
| Anxiety Disorder |
2.3% |
| Cutaneous Lupus Erythematosus |
2.3% |
| Dermatitis |
2.3% |
| Dermatitis Atopic |
2.3% |
| Dermatomyositis |
2.3% |
| Osteopenia |
2.3% |
| Pruritus |
2.3% |
| Skin Inflammation |
2.3% |
|
| Drug Ineffective |
10.0% |
| Alopecia |
6.7% |
| Application Site Pain |
6.7% |
| Ocular Hyperaemia |
6.7% |
| Paranasal Sinus Hypersecretion |
6.7% |
| Trichorrhexis |
6.7% |
| Trismus |
6.7% |
| Vomiting |
6.7% |
| Wrong Technique In Drug Usage Process |
6.7% |
| Application Site Erythema |
3.3% |
| Application Site Pruritus |
3.3% |
| Burning Sensation |
3.3% |
| Erythema |
3.3% |
| Expired Drug Administered |
3.3% |
| Hyperaesthesia |
3.3% |
| Inappropriate Schedule Of Drug Administration |
3.3% |
| Incorrect Drug Administration Duration |
3.3% |
| Loss Of Consciousness |
3.3% |
| Mastication Disorder |
3.3% |
| Muscle Spasms |
3.3% |
|
| Secondary |
| Alopecia Totalis |
46.2% |
| Dermatitis |
15.4% |
| Genital Herpes |
15.4% |
| Rash |
15.4% |
| Psoriasis |
7.7% |
|
| Growth Retardation |
33.3% |
| Wrong Technique In Drug Usage Process |
33.3% |
| Drug Administered At Inappropriate Site |
16.7% |
| Psoriasis |
16.7% |
|
| Concomitant |
| Psoriasis |
35.8% |
| Product Used For Unknown Indication |
13.6% |
| Drug Use For Unknown Indication |
8.6% |
| Rheumatoid Arthritis |
7.5% |
| Hypertension |
5.2% |
| Psoriatic Arthropathy |
5.0% |
| Vitamin Supplementation |
4.2% |
| Depression |
3.3% |
| Diabetes Mellitus |
1.9% |
| Pain |
1.9% |
| Anxiety |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Contraception |
1.5% |
| Hypothyroidism |
1.5% |
| Gout |
1.0% |
| Hypersensitivity |
1.0% |
| Insomnia |
1.0% |
| Supplementation Therapy |
1.0% |
| Bipolar Disorder |
0.8% |
|
| Psoriasis |
9.3% |
| Squamous Cell Carcinoma Of Skin |
9.3% |
| Hypotension |
7.4% |
| Vaginal Discharge |
7.4% |
| Cardiac Failure Congestive |
5.6% |
| Endometrial Cancer Recurrent |
5.6% |
| Gait Disturbance |
5.6% |
| Stress Urinary Incontinence |
5.6% |
| Abortion Spontaneous |
3.7% |
| Death |
3.7% |
| Endometrial Cancer |
3.7% |
| Injection Site Erythema |
3.7% |
| Injection Site Pain |
3.7% |
| Muscular Weakness |
3.7% |
| Myocardial Infarction |
3.7% |
| Nausea |
3.7% |
| Pain |
3.7% |
| Transient Ischaemic Attack |
3.7% |
| Tuberculin Test Positive |
3.7% |
| Urinary Tract Infection |
3.7% |
|
